SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-048664
Filing Date
2024-04-26
Accepted
2024-04-26 07:57:27
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq Description Document Type Size
1 ARS ars_10-k_2023.pdf ARS 1514932
  Complete submission text file 0000950170-24-048664.txt   2087869
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41855 | Film No.: 24878846
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)